Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments (Details Narrative)

v3.19.1
Derivative Financial Instruments (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
May 18, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Sep. 27, 2018
Dec. 31, 2017
Warrrant exercise price           $ 0.10  
Derivative liability   $ 34,369   $ 34,369    
Change in fair value   $ 7,524 $ 4,357    
Amended and Restated Loan Agreement [Member]              
Warrants to acquire of common stock 320,000            
Warrrant exercise price $ 0.10            
Derivative liability $ 30,012